标题
mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People
作者
关键词
-
出版物
Viruses-Basel
Volume 14, Issue 4, Pages 748
出版商
MDPI AG
发表日期
2022-04-02
DOI
10.3390/v14040748
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV – but HIV viremia matters?
- (2022) Xinling Xu et al. AIDS
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
- (2021) Marie Scully et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- (2021) Andreas Greinacher et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Vaccine Hesitancy among French People Living with HIV
- (2021) Alexandre Vallée et al. Vaccines
- Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
- (2021) Bezawit A Woldemeskel et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
- (2021) Itzchak Levy et al. CLINICAL MICROBIOLOGY AND INFECTION
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
- (2021) Robert W. Frenck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- (2021) John Frater et al. Lancet HIV
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
- (2021) Shabir A Madhi et al. Lancet HIV
- Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
- (2021) Nils Jedicke et al. HIV MEDICINE
- Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
- (2021) Daniel K Nomah et al. Lancet HIV
- Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
- (2021) Xueying Yang et al. Lancet HIV
- Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
- (2020) Ning Wang et al. Frontiers in Microbiology
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Clinical features and outcomes of HIV patients with coronavirus disease 2019
- (2020) Cristina Gervasoni et al. CLINICAL INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- The pandemic pipeline
- (2020) John Hodgson NATURE BIOTECHNOLOGY
- COVID-19 in patients with HIV: clinical case series
- (2020) Jose L Blanco et al. Lancet HIV
- Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
- (2020) Pilar Vizcarra et al. Lancet HIV
- Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV
- (2020) Eric A. Meyerowitz et al. AIDS
- Recent advances in mRNA vaccine technology
- (2020) Norbert Pardi et al. CURRENT OPINION IN IMMUNOLOGY
- Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review
- (2020) TJ Cooper et al. HIV MEDICINE
- One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4+ T-cell count
- (2020) Maomao Wang et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Descriptive Analysis of Patients Living with HIV Affected By COVID-19
- (2020) Smitha Gudipati et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan, China
- (2020) Wei Guo et al. Journal of the International AIDS Society
- SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States
- (2020) Katrina M Byrd et al. Journal of the International AIDS Society
- Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study
- (2020) Valerie M Vaughn et al. CLINICAL INFECTIOUS DISEASES
- Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19
- (2020) Dima Dandachi et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa
- (2020) Andrew Boulle et al. CLINICAL INFECTIOUS DISEASES
- Clinical outcomes of patients with COVID‐19 and HIV coinfection
- (2020) Sandhya R. Nagarakanti et al. JOURNAL OF MEDICAL VIROLOGY
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Use of adenovirus type-5 vectored vaccines: a cautionary tale
- (2020) Susan P Buchbinder et al. LANCET
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
- (2020) Liqiang Feng et al. Nature Communications
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- (2020) Jordan R. Barrett et al. NATURE MEDICINE
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombination events are concentrated in the spike protein region of Betacoronaviruses
- (2020) Louis-Marie Bobay et al. PLoS Genetics
- HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
- (2020) Krishnan Bhaskaran et al. Lancet HIV
- Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions
- (2019) Alexander T. Baker et al. Nature Communications
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- A review of 65 years of human adenovirus seroprevalence
- (2019) Franck J. D. Mennechet et al. Expert Review of Vaccines
- A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
- (2019) Markus Baiersdörfer et al. Molecular Therapy-Nucleic Acids
- Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir
- (2019) Leonardo Calza et al. INFECTION
- Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
- (2019) Sergio Linares-Fernández et al. TRENDS IN MOLECULAR MEDICINE
- State‐of‐the‐art human adenovirus vectorology for therapeutic approaches
- (2019) Jian Gao et al. FEBS LETTERS
- Human adenovirus infections
- (2018) Jay R. Radke et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Adenovirus respiratory tract infections in infants: a retrospective chart-review study
- (2018) Shaden Jobran et al. LANCET
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection
- (2018) Sarah Auclair et al. PLoS Pathogens
- Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
- (2018) Sriram Vaidyanathan et al. Molecular Therapy-Nucleic Acids
- Vaccine development for human mastadenovirus
- (2018) Shiying Chen et al. Journal of Thoracic Disease
- New Vaccine Technologies to Combat Outbreak Situations
- (2018) Susanne Rauch et al. Frontiers in Immunology
- Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
- (2018) Alexandra G. Orlandini von Niessen et al. MOLECULAR THERAPY
- Novel viral vectors in infectious diseases
- (2017) Ian R. Humphreys et al. IMMUNOLOGY
- Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them
- (2017) Kathrin Leppek et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Persistence and reactivation of human adenoviruses in the gastrointestinal tract
- (2016) K. Kosulin et al. CLINICAL MICROBIOLOGY AND INFECTION
- Regulation of Poly(A) Tail and Translation during the Somatic Cell Cycle
- (2016) Jong-Eun Park et al. MOLECULAR CELL
- Structural basis for m7G recognition and 2′-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I
- (2016) Swapnil C. Devarkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences
- (2016) Alexandra E Grier et al. Molecular Therapy-Nucleic Acids
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Stability analysis of chemically modified mRNA using micropattern-based single-cell arrays
- (2015) Mehrije Ferizi et al. LAB ON A CHIP
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Decreased functional T lymphocyte-mediated cytokine responses in patients with chemotherapy-induced neutropenia
- (2013) L. Öhrmalm et al. JOURNAL OF INTERNAL MEDICINE
- Cardiovascular Disease and HIV Infection
- (2013) Virginia A. Triant Current HIV/AIDS Reports
- Cationic lipids activate intracellular signaling pathways
- (2012) Caroline Lonez et al. ADVANCED DRUG DELIVERY REVIEWS
- Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+T Cells Induced by Different Adenovirus Vectors
- (2012) Wendy G. Tan et al. JOURNAL OF VIROLOGY
- Adenovirus
- (2012) Marc Tebruegge et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
- (2011) B. R. Anderson et al. NUCLEIC ACIDS RESEARCH
- Adenoviruses in Lymphocytes of the Human Gastro-Intestinal Tract
- (2011) Soumitra Roy et al. PLoS One
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Coronavirus Diversity, Phylogeny and Interspecies Jumping
- (2009) Patrick C. Y. Woo et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Severe Pneumonia Due to Adenovirus Serotype 14: A New Respiratory Threat?
- (2008) J. K. Louie et al. CLINICAL INFECTIOUS DISEASES
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now